Executive Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $530K | Buy |
2,984
+81
| +3% | +$14.4K | 0.04% | 160 |
|
|
2024
Q3 | $573K | Buy |
2,903
+78
| +3% | +$15.4K | 0.05% | 161 |
|
|
2024
Q2 | $484K | Buy |
2,825
+130
| +5% | +$22.3K | 0.09% | 79 |
|
|
2024
Q1 | $487K | Buy |
2,695
+77
| +3% | +$13.9K | 0.04% | 152 |
|
|
2023
Q4 | $406K | Buy |
2,618
+313
| +14% | +$48.5K | 0.04% | 156 |
|
|
2023
Q3 | $344K | Buy |
2,305
+248
| +12% | +$37K | 0.04% | 156 |
|
|
2023
Q2 | $277K | Sell |
2,057
-198
| -9% | -$26.7K | 0.03% | 164 |
|
|
2023
Q1 | $359K | Sell |
2,255
-38
| -2% | -$6.06K | 0.04% | 149 |
|
|
2022
Q4 | $371K | Buy |
2,293
+1,993
| +664% | +$322K | 0.05% | 146 |
|
|
2022
Q3 | $300 | Sell |
300
-1,942
| -87% | -$1.94K | 0.04% | 147 |
|
|
2022
Q2 | $343K | Sell |
2,242
-239
| -10% | -$36.6K | 0.05% | 141 |
|
|
2022
Q1 | $402K | Sell |
2,481
-19
| -0.8% | -$3.08K | 0.04% | 143 |
|
|
2021
Q4 | $338K | Sell |
2,500
-82
| -3% | -$11.1K | 0.03% | 156 |
|
|
2021
Q3 | $278K | Sell |
2,582
-103
| -4% | -$11.1K | 0.03% | 155 |
|
|
2021
Q2 | $302K | Buy |
2,685
+214
| +9% | +$24.1K | 0.03% | 156 |
|
|
2021
Q1 | $267K | Buy |
2,471
+10
| +0.4% | +$1.08K | 0.03% | 163 |
|
|
2020
Q4 | $263K | Buy |
+2,461
| New | +$263K | 0.03% | 151 |
|
|
2019
Q3 | – | Sell |
-3,094
| Closed | -$225K | – | 137 |
|
|
2019
Q2 | $225K | Sell |
3,094
-401
| -11% | -$29.2K | 0.03% | 150 |
|
|
2019
Q1 | $282K | Sell |
3,495
-1,065
| -23% | -$85.9K | 0.05% | 129 |
|
|
2018
Q4 | $420K | Buy |
+4,560
| New | +$420K | 0.07% | 114 |
|